Partnerships
As part of Pronota’s product development process for the biomarkers it has discovered, the company develops and optimizes its own first generation assays, conducts clinical development studies utilizing these tests and then seeks regulatory clearance or approval if the clinical studies are successful. Pronota is open to discuss licensing deals on its product development programs at various stages of this process.
Pronota is interested in partnerships with leading diagnostic laboratory instrument manufacturers for the development and commercialization of its products on their platforms. The company believes that focusing on novel content for existing automated laboratory instruments will facilitate broader and more rapid adoption of its diagnostic tests.
Pronota’s platform also allows it to initiate a structured process for discovering biomarkers for high-value market opportunities that are identified in conjunction with its partners.